{
"item_title" : "Cancer Vaccines",
"item_author" : [" Adrian Bot", "Mihail Obrocea", "Francesco M. Marincola "],
"item_description" : "Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: From Research to Clinical Practice is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist.Cancer Vaccines: From Research to Clinical Practice:Analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potentialDiscusses theranostics as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapyPresents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancerReviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them",
"item_img_path" : "https://covers2.booksamillion.com/covers/bam/1/13/811/260/1138112607_b.jpg",
"price_data" : {
"retail_price" : "102.99", "online_price" : "102.99", "our_price" : "102.99", "club_price" : "102.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : ""
}
}
Cancer Vaccines : From Research to Clinical Practice
Other Available Formats
Overview
Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: From Research to Clinical Practice is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist.
Cancer Vaccines: From Research to Clinical Practice:
- Analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential
- Discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy
- Presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer
- Reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them
This item is Non-Returnable
Customers Also Bought
Details
- ISBN-13: 9781138112605
- ISBN-10: 1138112607
- Publisher: CRC Press
- Publish Date: September 2017
- Page Count: 296
Related Categories
